Emergence of resistance by bacterial and fungal stains towards existing antimicrobial agents is one of the major problem as well as motivation to synthesize a new class of antimicrobial agents possessing potent activity compared to commonly used therapy. Coumarin is the heterocyclic compound formed from benzene and pyrone ring containing oxygen and its derivatives are of wide awareness because of their diverse biological activity and clinical applications, they are remarkably effective compounds both with respect to their inhibitory activity and their favourable selectivity ratio. Coumarins are regarded as a promising class of bioactive heterocyclic compounds that exhibit a range of biological activities like anti-microbial, anti-viral, anti-diabetic, anti-cancer activity, anti-oxidant, anti-parasitic, antihelmintic, anti-proliferative, anti-convulsant, anti-inflammatory and anti-hypertensive activities etc. The information given in this manuscript may be helpful in the further research of better antimicrobial agents having lesser microbial resistance and improved antimicrobial profile.
INTRODUCTION
There are a number of reports that natural and synthetic Coumarin derivatives posses antimicrobial activity. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Novobiocin and Chlorobiocin are established antimicrobials containing a Coumarin (i.e.2H-1-benzopyran-2-ones) skeleton, there are many Coumarin derivatives which have been reported for anticoagulant, anti-inflammatory, anti-HIV, antioxidant, anti-allergic, anti-cancer, anti proliferative and antiviral activities. [15] [16] [17] It was found that when one biodynamic heterocyclic system was coupled with another heterocyclic system, enhanced biological activity was produced. Drug resistance has become a growing problem in the treatment of infectious diseases caused by bacteria and fungi. 18 The serious medical problem of bacterial and fungal resistance and the rapid rate at which it develops has led to increasing levels of resistance to classical antibiotics, 19, 20 and the discovery and development of effective antibacterial and antifungal drugs with novel mechanisms of action have thus become urgent tasks for infectious disease research programs. 21 Coumarins present a variety of bioactivities, including anticoagulant, estrogenic, dermal photosensitizing, antimicrobial, vasodilator, molluscicidal, antihelmintic, sedative and hypnotic, analgesic and hypothermic actions. 22 Furthermore, the pharmacological properties as well as therapeutic applications of coumarins depend upon the pattern of substitution and recently they are reported to possess many pharmacological activities such as antimicrobial activity. In continuation of previous studies [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] on coumarins, herein we are reporting a review for such recent derivatives of coumarins with antioxidant activities.
ANTIMICROBAL ACTIVITY
Olayinka O. Ajani et al. reported synthesis and biological activities of some substituted coumarins All the compounds (1, 2, 3, 4) showed good activity against Staphylococcus aureus and Escherichia coli and, Bacillus subtilis. 33 Al-Amiery et al. have synthesized 4-[(5-mercapto-4-phenyl-4H-1,2,4-triazol-3-yl)-methoxy]-2H-chromen-2-one as coumarin derivatives and their antifungal activity was determined based on the growth inhibition rates of the mycelia of strains of Aspergillus niger and Candida albicans in Potato Dextrose Broth medium (PDB) against concentrations ranging from 10 to 100µgml -1 . Two compounds (5, 6) showed good activity as antifungals against fluconazole standard drug. 34 Behrami et al. synthesized 8-amino-4,7-dihydroxy-chromen-2-one coumarin derivatives. The antibacterial activities of all the compounds and standard streptomycin and cefalexine at concentractions of 2 mgml -1 , 3 mgml -1 and 5mgml -1 were studied against Staphylococcus aureus, Bacillus subtilis and Escherichia coli. One compound (7) was more active than cefalexine and lesser active than streptomycin and it was most active among synthesized compounds. 35 Vyas et al. synthesized some novel 3-[{(3-(2'-Nitrophenyl)}-prop-2-enoyl]-4-hydroxy-6-methyl-2H-chromene-2-ones (8) ) Cephalosporins showed a potential activity against Gram positive microorganisms and sulfones showed no significant activity. An association of sulfone with ampicillin was observed to inhibit Gram positive microorganisms with a lower MIC value than for ampicillin alone. 38 Novel coumarin derivatives were synthesised by Sahoo et al. and antibacterial activity was tested against Gram positive bacteria i.e. Staphylococcus aureus and Gram negative bacteria i.e. Escherichia coli. DMSO was used as a control. One compound (10) possessed maximum antibacterial activity as compared to standard drug amoxicillin which may be due to presence of chlorine on aromatic ring of coumarins. Other compounds also showed mild to moderate activity at 0.1ml concentration level on both organisms. 39 Purohit et al reported synthesis and biological activities of some substituted 3-(4-hydroxybenzoyl)-1H-isochromen-1-one ,2-benzopyran-1H-2-one,1H-2-oxo-benzopyran-3-carboxylicacids and 2-benzofuran-1H-one. All the compounds showed good activity against Staphylococcus aureus and Escherichia coli. ) by replacing the hydrogen atom attached to the coumarin nucleus at C-3 with a side chain, while the other compounds with other side chains showed moderate to weak activity. 41 Mulwad VV et al. synthesized some heterocycles by incorporating isoxazoles, pyromidines and 1,5-benzothiazeoine in a parent 4-hydroxycoumarin molecule which enhanced the biological properties of these molecules. These compounds were tested for in vitro antibacterial activity. 42 Gupta AS et al. synthesized 3-amino-(N-aryl substituted)-6-bromo-2H-1-benzopyran-2-ones and 6-bromo-3-phenoxy substituted-2H-1-benzopyran-2-ones. All the title compounds were screened for in-vitro antitubercular activity against highly virulent H37Rv strains of mycobacterium tuberculosis as compared to streptomycin and INH. 43 Some derivatives of (7-hydroxy-2-oxo-2H-chromen-4-yl)-acetic acid hydrazide (16) against all the tested organisms. 50 Hamdi et al synthesized bis[N-(4-oxocoumarinylmethylene)]-1,4-diamines and the antibacterial activity tests were carried out using Staphylococcus aureus ATCC 25923 at a concentration of 106CFCml-1 on the surface of a Mueller-Hint on gelose plate. One compound exhibited the strongest antibacterial activity. 51 Mashelkar et al. synthesized some novel 4-substituted coumarins and subjected them to in-vitro screening against Gram positive Staphylococcus aureus and Gram negative Salmonella typhi. Ampicillin and trimethoprim were used as standard drugs. Two compounds (18a-18b) showed significant antibacterial activity at concentration levels of 10 to 200µgml -1 against Staphylococcus aureus and Salmonella typhi. . One compound (21) was more active against Staphylococcus aureus, Escherichia coli and Enterobacter cloaco and not active as antimicrobial agent against Hafnia alvei and Pseudomonas aeruginosa. 55 
Mulwad VV et al. synthesized 4-[1-(2H-[1]-4-hydroxy-2-oxo-benzopyran-3-yl)methylidene]-2-phenyl-4H-oxazol-5-ones and [1,2,4]triazine-
6-one and its derivatives. All the compounds were screened for antimicrobial activity and found to exhibit significant activity. 56 A novel series of 5H,7H-N-(coumarin-6-yl)-2,8-diphenyl-5,7-dioxo-6-(7-methoxy-4-methyl coumarin-6-yl)-4,5,6,7-tetrahydrobenzimidazo [5,6- µgml -1 range, indicating that the presence of an acyl function is an important feature for activity. 59 Patel AK et al. synthesized some 4-aryl-2,6-di(coumarin-3-yl)pyridines (25) and were tested for antimicrobial activity. None of the compounds showed antifungal activity against Aspergillus niger. The results revealed that the incorporation of the substituents like -CH 3 or -OCH 3 either in the coumarin nucleus or in a phenyl ring did not affect the antibacterial activity much more and all the compounds had almost same activity. Activity of some compounds indicated that the presence of an additional fused benzene ring between the C-5' and C-6' positions inhibited the anti-bacterial activity towards Escherichia coli. (27) and were screened for anti-bacterial activity against Escherichia coli, Bacillus subtillis and anti-fungal activity against Candida albican by agar cup diffusion method. DMF was used as blank, Streptomycin was used as anti-bacterial standard and Clotrimazole as anti-fungal standard drug at concentration of 1000 µgml -1 . All the synthesized compounds showed activity against both gram positive and gram negative bacteria but lesser activity compared to standard drug. 
coli stains and antifungal activity against Clostridium albicans. Ciprofloxacin and ketoconazole were used as the standard antibacterial and antifungal drugs respectively. The test compounds and standards drugs were evaluated at concentration of 100µg/mL. DM F (N,N-dimethylformamide) was used as solvent and control. One compound (28) showed 92%, 80% and 90% growth inhibition against Staphylococcus aureus, Escherichia coli and Clostridium albicans respectively. 63 Creaven et al. prepared a series of Schiff bases and Cu(II) complexes (29a-29b). All of the free ligands and their metal complexes were tested for their antifungal activity compared with ketoconazole and amphotericin B. The ligands showed no antimicrobial activity whereas a number of the metal complexes exhibited potent antimicrobial activity when compared with their respective standard drugs. . Amoxicillin was standard for antibacterial activity and fluconazole for antifungal activity. 65 Hafnia alvei, Pseudomonas aeruginosa and Enterobacter cloacae. The Agar disc diffusion technique measured the diameters of the inhibition zone around discs which were previously wetted with N,N-DMF solu- ) were used as standard drugs for antibacterial and antifungal activities respectively. Among the compounds tested for antibacterial activity, one compound (35) showed highest zone of inhibition against S. aureus and B. subtilis and minimum inhibition against E. coli and P. aeruginosa. The remaining compounds exhibited moderate activity. 70 Basanagouda et al. synthesized 4-aryloxmethylcoumarins (36) and screened for their antibacterial and antifungal activity at different concentrations of 500, 250, 100 and 50 µgml-1 by the disc diffusion method. Antibacterial activity was carried out against two Gram positive bacteria, viz. Staphylococcus aureus, and Streptococcus faecalis and three Gram negative bacteria, viz. Escherichia coli, Psuedomonus aeruginosa, Klebsiella pneumonia. Antifungal activity was carried out against five fungi, viz. Aspergillus flavus, Aspergillus fumigatus, Candida albicans, Penicillium notatum and Rhizopus. Ciprofloxacin and Fluconazole were used as standard antibacterial and antifungal drug respectively. The compounds possessing methoxy, chloro, bromo substituents at C-6 position of cou-marin showed higher activity. 71 
CONCLUSION
In summary, studies evaluating the antimicrobial activities elicited by coumarinswhich have currently expanded and, though there is plenty of in vitro evidence to back up the antimicrobial activities of these compounds, the in vivo studies available notably indicate the need to interpret data with caution. In this context, the real antimicrobial effect obtained from oral ingestion of either synthesized or natural compounds and more specifically the suitable dose to achieve this effect for several compounds is still to be proved in vivo. Recent studies point towards the rational development of less toxic and more potent compounds which might be clinically utilized in treatment of patients suffering from diseases. However, in spite of tangible advances in drug design and Medicinal Chemistry, there are still few potent pharmacological agents being adopted as antimicrobail in clinical phase. The advances in this field have led to the design and synthesis of new promising prototypes with coumarin. Indeed, these compounds possess several biological activities and their structures allow diverse substitutions and draw much interest considering the possibilities of synthesizing new antimicrobail compounds.
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ABBREVIATION USED
PDB: Potato Dextrose Broth medium; E-coli: Escherichia coli; Coumarin: 2H-[1]-benzo¬pyran-2-one; Ag: Silver; DMF: N,N-dimethylformamide.
